BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 28223235)

  • 1. Interleukin 32, inflammation and cancer.
    Hong JT; Son DJ; Lee CK; Yoon DY; Lee DH; Park MH
    Pharmacol Ther; 2017 Jun; 174():127-137. PubMed ID: 28223235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
    Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the role of IL-32 in cancer.
    Sloot YJE; Smit JW; Joosten LAB; Netea-Maier RT
    Semin Immunol; 2018 Aug; 38():24-32. PubMed ID: 29747940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting interleukin-21 in inflammatory diseases.
    Sarra M; Franzè E; Pallone F; Monteleone G
    Expert Opin Ther Targets; 2011 Jun; 15(6):695-702. PubMed ID: 21391901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Action and Applications of Interleukin 24 in Immunotherapy.
    Persaud L; De Jesus D; Brannigan O; Richiez-Paredes M; Huaman J; Alvarado G; Riker L; Mendez G; Dejoie J; Sauane M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
    Taniguchi K; Karin M
    Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology.
    Voronov E; Apte RN
    Curr Pharm Des; 2017; 23(32):4893-4905. PubMed ID: 28606052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-32 in Pathogenesis of Atopic Diseases: Proinflammatory or Anti-Inflammatory Role?
    Boreika R; Sitkauskiene B
    J Interferon Cytokine Res; 2021 Jul; 41(7):235-243. PubMed ID: 34280028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21 as a therapeutic target in inflammatory disorders.
    Di Fusco D; Izzo R; Figliuzzi MM; Pallone F; Monteleone G
    Expert Opin Ther Targets; 2014 Nov; 18(11):1329-38. PubMed ID: 25162763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting interleukin-22 for cancer therapy.
    Markota A; Endres S; Kobold S
    Hum Vaccin Immunother; 2018; 14(8):2012-2015. PubMed ID: 29617184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells.
    Schmieder A; Multhoff G; Radons J
    Cytokine; 2012 Nov; 60(2):514-21. PubMed ID: 22819319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-21: roles in immunopathology and cancer therapy.
    Søndergaard H; Skak K
    Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-23 promotes tumour incidence and growth.
    Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
    Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-22 and inflammation: leukin' through a glass onion.
    Zenewicz LA; Flavell RA
    Eur J Immunol; 2008 Dec; 38(12):3265-8. PubMed ID: 19016525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-21 Signaling in the Tumor Microenvironment.
    Chabab G; Bonnefoy N; Lafont V
    Adv Exp Med Biol; 2020; 1240():73-82. PubMed ID: 32060889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
    Schmitz J; Owyang A; Oldham E; Song Y; Murphy E; McClanahan TK; Zurawski G; Moshrefi M; Qin J; Li X; Gorman DM; Bazan JF; Kastelein RA
    Immunity; 2005 Nov; 23(5):479-90. PubMed ID: 16286016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-related interleukins: old validated targets for new anti-cancer drug development.
    Setrerrahmane S; Xu H
    Mol Cancer; 2017 Sep; 16(1):153. PubMed ID: 28927416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation.
    Ouyang W; O'Garra A
    Immunity; 2019 Apr; 50(4):871-891. PubMed ID: 30995504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene of the month: Interleukin 6 (IL-6).
    Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
    J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-21 signaling: functions in cancer and autoimmunity.
    Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV
    Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.